-
Spatial genomic heterogeneity in multiple myeloma revealed by multi- region sequencing
Study
EGAS00001002111
-
TRACERx Renal 100
Study
EGAS00001002793
-
Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif
Study
EGAS00001003719
-
Roma Sequencing Study
Study
EGAS00001004287
-
Whole-exome sequencing of hepatocellular carcinoma biopsies (proteogenomic study)
Study
EGAS00001005073
-
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
Study
EGAS00001005420
-
Spatial concordance of DNA methylation classification in diffuse glioma
Study
EGAS00001005434
-
Targeted sequencing of diffuse large B-cell lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001005953
-
Molecular programs of melanoma brain metastases (MBM)
Study
EGAS00001005976
-
Whole-Transcriptomic Profiling of Sorted Human Renal Cell Carcinoma Immune Populations
Study
EGAS00001006593
-
NIBIT-M4 Clinical Trial samples
Study
EGAS00001006736
-
Diet driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Study
EGAS00001006982
-
Molecular features of adenomas predicting metachronous colorectal cancer: a nested-case control study
Study
EGAS00001007039
-
The genomic landscape of recurrent ovarian high grade serous carcinoma: the BriTROC-1 study
Study
EGAS00001007292
-
Study of non-clear cell renal cell carcinoma
Study
EGAS00001000926
-
Immune trajectory of response and adverse effect in immunotherapy-treated hepatocellular carcinoma
Study
EGAS00001004843
-
Identification of gene mutations and fusion genes in patients with Sézary Syndrome
Study
EGAS00001001706